Nektar Therapeutics (NKTR) Deferred Taxes (2022 - 2024)
Nektar Therapeutics' (NKTR) quarterly Deferred Taxes came in at -$31000.0 in Q3 2024, down 106.67% year-on-year from $465000.0 in Q4 2023, and down 154.39% quarter-over-quarter from $57000.0 in Q2 2024.
Nektar Therapeutics (NKTR) Deferred Taxes (2022 - 2024) Analysis & Trends
Nektar Therapeutics' Deferred Taxes history runs 3 years deep, the most recent figure standing at -$31000.0 for Q3 2024.
- On a quarterly basis, Deferred Taxes fell 106.67% year-over-year to -$31000.0 in Q3 2024; TTM through Sep 2024 was $1.7 million, a 99.3% increase from a year earlier, with the FY2023 full-year figure at -$140000.0, down 105.17% from the prior year.
- Deferred Taxes slipped to -$31000.0 in Q3 2024 per NKTR's latest filing, from $57000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $2.7 million in Q4 2022 and bottomed at -$1.8 million in Q1 2023.
- The 3-year median for Deferred Taxes is -$21000.0 (2023), against an average of $319500.0.
- Biggest YoY gain for Deferred Taxes was 311.11% in 2024; the steepest drop was 106.67% in 2024.
- Year by year, Deferred Taxes stood at $2.7 million in 2022, then tumbled by 36.71% to $1.7 million in 2023, then tumbled by 101.81% to -$31000.0 in 2024.
- Per Business Quant, the three latest NKTR Deferred Taxes figures stand at -$31000.0 (Q3 2024), $57000.0 (Q2 2024), and -$38000.0 (Q1 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Nektar Therapeutics | 2.04 Bn | 1.48 Bn | 3.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | 57,000.00 |
| Mar 31, 2024 | -38,000.00 |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | -15,000.00 |
| Jun 30, 2023 | -27,000.00 |
| Mar 31, 2023 | -1.81 Mn |
| Dec 31, 2022 | 2.71 Mn |